首页>
外国专利>
THE USE OF SULINDAC AND/OR ITS METABOLITE AS ADJUVANT TREATMENT FOR COLON CANCER IN HUMANS
THE USE OF SULINDAC AND/OR ITS METABOLITE AS ADJUVANT TREATMENT FOR COLON CANCER IN HUMANS
展开▼
机译:SULINDAC和/或其代谢物作为人类结肠癌的辅助治疗方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The use of sulindac and/or its metabolite in combination with cytostatic drugs as adjuvant treatment for colon cancer in humans. The cytostatic is selected from a group including: 5-f luorouracil, capecitabine, oxaliplatin, leucovorin and irinotecan and/or their combinations.
展开▼